Adaptive Biotechnologies Corp. (ADPT)
16.42
-0.23
(-1.38%)
USD |
NASDAQ |
Dec 30, 16:00
16.40
-0.02
(-0.15%)
After-Hours: 20:00
Adaptive Biotechnologies Total Assets (Quarterly): 490.61M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Zymeworks, Inc. | 397.27M |
| Cue Biopharma, Inc. | 31.64M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| Arcellx, Inc. | 655.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 286.36M |
| Shareholders Equity (Quarterly) | 204.44M |
| Debt to Equity Ratio | 1.045 |
| Current Ratio | 3.376 |
| Net Debt Paydown Yield | 0.11% |